Lerato Mohapi

3.7k citations

35 papers · 1.5k indexed · h-index 20

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology

Papers in ⓘ

Virology 15
- HIV Research and Treatment 15
Infectious Diseases 29
- HIV/AIDS Research and Interventions 18
- HIV/AIDS drug development and treatment 18
- Tuberculosis Research and Epidemiology 3

Co-authors: Neil Martinson (11 shared papers)Glenda Gray (10 shared papers)James McIntyre (6 shared papers)Jonathan E. Golub (3 shared papers)Richard E. Chaisson (5 shared papers)Fatima Laher (6 shared papers)Nkeko Tshabangu (5 shared papers)Mosa Moshabela (3 shared papers)
Journals: AIDS (9 papers)PLoS ONE (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)AIDS and Behavior (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: South Africa United States Thailand

In The Last Decade

Lerato Mohapi

34 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lerato Mohapi

Since Specialization

Citations

This map shows the geographic impact of Lerato Mohapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lerato Mohapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lerato Mohapi more than expected).

Fields of papers citing papers by Lerato Mohapi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lerato Mohapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lerato Mohapi. The network helps show where Lerato Mohapi may publish in the future.

Co-authors

The 25 scholars most cited alongside Lerato Mohapi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lerato Mohapi Line = papers co-authored together Lerato Mohapi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 AIDS ·Morna Cornell, Anna Grimsrud, Lara Fairall, Matthew P. Fox, Gilles Van Cutsem, Janet Giddy, Robin Wood, Hans Prozesky, Lerato Mohapi, Claire Graber, Matthias Egger, Andrew Boulle, Landon Myer	2010	187
2	Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort AIDS ·Jonathan E. Golub, Paul Pronyk, Lerato Mohapi, Nkeko Thsabangu, Mosa Moshabela, Helen Struthers, Glenda Gray, James McIntyre, Richard E. Chaisson, Neil Martinson	2009	180
3	Body mass index and risk of tuberculosis and death AIDS ·Colleen F. Hanrahan, Jonathan E. Golub, Lerato Mohapi, Nkeko Tshabangu, Tebogo Modisenyane, Richard E. Chaisson, Glenda Gray, James McIntyre, Neil Martinson	2010	115
4	Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study The Lancet ·(unknown), Mark Boyd, Nagalingeswaran Kumarasamy, Cecilia L. Moore, Chidi Nwizu, M Losso, Lerato Mohapi, Allison Martin, Stephen J. Kerr, A Sohn, Hedy Teppler, O. Van de Steen, Jean‐Michel Molina, Sean Emery	2013	109
5	Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS ·Ziad El‐Khatib, Anna Mia Ekström, Johanna Ledwaba, Lerato Mohapi, Fatima Laher, Alan Karstaedt, Salome Charalambous, Max Petzold, David Katzenstein, Lynn Morris	2010	102
6	Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa PLoS ONE ·Ziad El‐Khatib, David Katzenstein, Gaetano Marrone, Fatima Laher, Lerato Mohapi, Max Petzold, Lynn Morris, Anna Mia Ekström	2011	86
7	Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study The Lancet Infectious Diseases ·(unknown), Dianne Carey, Rebekah Puls, Janaki Amin, Marcelo Losso, Praphan Phanupak, Sharne Foulkes, Lerato Mohapi, Brenda Crabtree‐Ramírez, Heiko Jessen, Suresh Kumar, Alan Winston, Man‐Po Lee, Waldo Belloso, David A. Cooper	2015	73
8	A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions among HIV-Positive Women in Soweto, South Africa AIDS and Behavior ·Fatima Laher, Catherine S. Todd, Mark Stibich, Rebecca Phofa, Xoliswa Behane, Lerato Mohapi, Glenda Gray	2009	63
9	Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART AIDS ·David Adler, Lisa Kakinami, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Guy de Bruyn, Neil Martinson, Tanvier Omar	2012	60
10	Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort AIDS ·Tanvier Omar, Sheree Schwartz, Colleen F. Hanrahan, Tebogo Modisenyane, Nkeko Tshabangu, Jonathan E. Golub, James McIntyre, Glenda Gray, Lerato Mohapi, Neil Martinson	2010	54
11	Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics AIDS ·Kartik K. Venkatesh, Guy de Bruyn, Mark N. Lurie, Lerato Mohapi, Paul Pronyk, Mosa Moshabela, Edmore Marinda, Glenda Gray, Elizabeth W. Triche, Neil Martinson	2010	51
12	Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study BMC Medicine ·Conor Tweed, Genevieve H. Wills, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Cheryl Louw, Timothy D. McHugh, Carl M. Mendel, Sarah Meredith, Lerato Mohapi, Michael E. Murphy, Stephen R. Murray, Sara Murthy, Andrew Nunn, Patrick Phillips, Kasha P. Singh, Melvin Spigelman, Stephen H. Gillespie	2018	50
13	Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. PubMed ·Morna Cornell, Karl‐Günter Technau, Lara Fairall, Robin Wood, Harry Moultrie, Gilles Van Cutsem, Janet Giddy, Lerato Mohapi, Brian Eley, Patrick MacPhail, Hans Prozesky, Helena Rabie, Mary‐Ann Davies, Nicola Maxwell, Andrew Boulle, (unknown)	2009	47
14	Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention Clinical Infectious Diseases ·Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher	2015	45
15	Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa JAIDS Journal of Acquired Immune Deficiency Syndromes ·Neil Martinson, Lerato Mohapi, Darryl Bakos, Glenda Gray, James McIntyre, Charles B. Holmes	2009	36
16	Effect of gender and race on the week 48 findings in treatment‐naïve, HIV‐1‐infected patients enrolled in the randomized, phase III trials ECHO and THRIVE HIV Medicine ·Sally Hodder, Keikawus Arastéh, Joseph de Wet, Joseph Gathe, Julian Gold, Princy Kumar, Lerato Mohapi, William R. Short, Herta Crauwels, Simon Vanveggel, Katia Boven	2012	35
17	Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gesine Meyer‐Rath, Alana T. Brennan, Matthew P. Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen, Neil Martinson	2012	34
18	Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection PLoS ONE ·Janaki Amin, Mark Boyd, Nagalingeswaran Kumarasamy, Cecilia L. Moore, M Losso, Chidi Nwizu, Lerato Mohapi, Stephen J. Kerr, Annette H. Sohn, Hedy Teppler, Boris Renjifo, Jean‐Michel Molina, Sean Emery, David A. Cooper	2015	31
19	CD4 Counts and Viral Loads of Newly Diagnosed HIV-Infected Individuals: Implications for Treatment as Prevention PLoS ONE ·Sarishen Govender, Kennedy Otwombe, Thandekile Essien, Ravindre Panchia, Guy de Bruyn, Lerato Mohapi, Glenda Gray, Neil Martinson	2014	22
20	Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa Contraception ·Fatima Laher, Catherine S. Todd, Mark Stibich, Rebecca Phofa, Xoliswa Behane, Lerato Mohapi, Neil Martinson, Glenda Gray	2010	20

About Lerato Mohapi

Lerato Mohapi is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Microbiology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (18 papers), HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Adolescent Sexual and Reproductive Health (6 papers), HIV-related health complications and treatments (5 papers), HIV/AIDS Impact and Responses (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Virology (467 citations), Infectious Diseases (1.2k citations), Epidemiology (684 citations), Emergency Medicine (160 citations) and General Health Professions (218 citations). Lerato Mohapi has collaborated with scholars based in South Africa, United States and Thailand. Frequent co-authors include Neil Martinson, Glenda Gray, James McIntyre, Jonathan E. Golub, Richard E. Chaisson, Fatima Laher, Nkeko Tshabangu, Mosa Moshabela, Paul Pronyk and David Katzenstein. Their work appears in journals such as AIDS, PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Behavior and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact